- Spero Therapeutics (NASDAQ:SPRO) has agreed to sell $10M of its common stock to Novo Holdings A/S in a direct transaction.
- It will sell the stock in two tranches, ~466K shares at $10.73 (expected to close by tomorrow, June 14) for gross proceeds of $5M and $5M triggered by the earlier of Spero's announcement of pharmacokinetic data from the lead-in cohort in its Phase 3 study of SPR994 or June 30, 2020.
- Net proceeds will fund its SPR720 program.
- Yesterday's close was $10.61.
Spero secures $10M capital raise
Recommended For You
More Trending News
About SPRO Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
SPRO | - | - |
Spero Therapeutics, Inc. |